UMB Financial Corporation

Equities

Market Closed - Nasdaq Other stock markets 02:30:00 07/03/2026 am IST			5-day change	1st Jan Change
113.49 ^USD	-3.38%		-2.06%	-1.35%

04/02	UMB Financial Insider Sold Shares Worth $2,408,024, According to a Recent SEC Filing	MT
28/01	UMB Financial Corporation, Q4 2025 Earnings Call, Jan 28, 2026

Published on 04/29/2025 at 05:46 pm IST - Modified on 05/23/2025 at 10:51 pm IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Hello, and welcome to the Annual Meeting of Shareholders of UMB Financial Corporation. Please note that today's meeting is being recorded. [Operator

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

04/02	UMB Financial Insider Sold Shares Worth $2,408,024, According to a Recent SEC Filing	MT
28/01	UMB Financial Corporation, Q4 2025 Earnings Call, Jan 28, 2026
28/01	UMB Financial Keeps Quarterly Dividend at $0.43 a Share, Payable April 1 to Holders of Record March 10	MT
28/01	UMB Financial Q4 Adjusted Earnings, Revenue Rise	MT
28/01	Earnings Flash (UMBF) UMB Financial Corporation Posts Q4 Adjusted EPS $3.08 per Share, vs. FactSet Est of $2.70	MT
28/01	Earnings Flash (UMBF) UMB Financial Corporation Reports Q4 Revenue $720.9M, vs. FactSet Est of $677.8M	MT
28/01	UMB Financial Corporation Announces Net Charge-Offs for the Fourth Quarter Ended December 31, 2025	CI
28/01	UMB Financial Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2025	CI
28/01	UMB Financial Corporation Declares Quarterly Dividend, Payable on April 1, 2026	CI
28/01	UMB Financial Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
12/01	RBC Capital Adjusts Price Target on UMB Financial to $134 From $128, Maintains Outperform Rating	MT
13/12	UMB Financial Insider Sold Shares Worth $415,072, According to a Recent SEC Filing	MT
09/12	Umb Financial Insider Sold Shares Worth $1,760,751, According to a Recent SEC Filing	MT
02/12	Bristol-Myers' Bid to Dismiss Lawsuit Related to Celgene Acquisition Rejected by US Judge	MT
06/11	The Market Can't Make Up Its Mind